(Q39739481)

14 September 2017

title

Vav-1 expression correlates with NFκB activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines (English)

1 reference

diffuse large B-cell lymphoma

14 September 2017

1 reference

1 reference

6

1 reference

14 September 2017

7

1 reference

14 September 2017

Kristi Baker

3

0 references

Trevor Owens

object named as

Trevor Owens

series ordinal

5

0 references

Stephan Dirnhofer

series ordinal

4

object named as

Stephan Dirnhofer

1 reference

14 September 2017

Annette Hollmann

1

1 reference

14 September 2017

Raquel Aloyz

series ordinal

2

1 reference

14 September 2017

publication date

1 September 2010

1 reference

14 September 2017

published in

Hematological Oncology

1 reference

14 September 2017

volume

28

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

142-150

1 reference

Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

14 September 2017

cites work

1 reference

7 January 2021

The epidemiology of non-Hodgkin's lymphoma

1 reference

7 January 2021

Emerging prognostic factors in diffuse large B cell lymphoma

1 reference

7 January 2021

Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death

1 reference

7 January 2021

CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues

1 reference

7 January 2021

The CD40/CD154 receptor/ligand dyad

1 reference

7 January 2021

1 reference

7 January 2021

CD40-mediated apoptosis in murine B-lymphoma lines containing mutated p53.

1 reference

7 January 2021

Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin

1 reference

7 January 2021

Prospects for CD40-directed experimental therapy of human cancer

1 reference

7 January 2021

Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates

1 reference

7 January 2021

Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.

1 reference

7 January 2021

What is the real role of CD40 in cancer immunotherapy?

1 reference

7 January 2021

The role of Rel/NF-kappaB transcription factors in B lymphocyte survival

1 reference

7 January 2021

NF-kappaB and IKK as therapeutic targets in cancer

1 reference

7 January 2021

NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.

1 reference

7 January 2021

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology

1 reference

7 January 2021

Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications

1 reference

7 January 2021

Aberrant rel/nfkb genes and activity in human cancer

1 reference

7 January 2021

Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines

1 reference

7 January 2021

CDw40 and BLCa-specific monoclonal antibodies detect two distinct molecules which transmit progression signals to human B lymphocytes

1 reference

7 January 2021

TM4: a free, open-source system for microarray data management and analysis

1 reference

7 January 2021

Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome

1 reference

7 January 2021

Angiogenesis in nodal B cell lymphomas: a high throughput study.

1 reference

7 January 2021

Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases

1 reference

7 January 2021

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

7 January 2021

Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal–regulated kinase, and phosphorylated AKT in colorectal cancer—A tissue microarray–based approach?

1 reference

7 January 2021

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.

1 reference

7 January 2021

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

7 January 2021

The protein kinase PKR: a molecular clock that sequentially activates survival and death programs

1 reference

7 January 2021

Vav proteins regulate peripheral B-cell survival

1 reference

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

7 January 2021

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

7 January 2021

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

7 January 2021

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 reference

7 January 2021

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma

1 reference

7 January 2021

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways

1 reference

7 January 2021

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib*

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.935

1 reference

14 September 2017

1 reference